Anti-Moesin Antibodies in the Serum of Patients with Aplastic Anemia Stimulate Peripheral Blood Mononuclear Cells to Secrete TNF-α and IFN-γ
Authors:
- 1 January 2009
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 182 (1) , 703-710
Abstract
Moesin is an intracellular protein that links the cell membrane and cytoskeleton, while also mediating the formation of microtubules and cell adhesion sites as well as ruffling of the cell membrane. To determine the roles of anti-moesin Abs derived from the serum of patients with aplastic anemia (AA) in the pathophysiology of bone marrow failure, we studied the expression of moesin on various blood cells and the effects of anti-moesin Abs on the moesin-expressing cells. The proteins recognized by anti-moesin mAbs were detectable on the surface of T cells, NK cells, and monocytes from healthy individuals as well as on THP-1 cells. The peptide mass fingerprinting of the THP-1 cell surface protein and the knock-down experiments using short hairpin RNA proved that the protein is moesin itself. Both the anti-moesin mAbs and the anti-moesin polyclonal Abs purified from the AA patients’ sera stimulated THP-1 cells and the PBMCs of healthy individuals and AA patients to secrete 60–80% as much TNF-α as did LPS 100 ng/ml. Although the polyclonal Abs induced IFN-γ secretion from the PBMCs of healthy individuals only when the PBMCs were prestimulated by anti-CD3 mAbs, the anti-moesin Abs were capable of inducing IFN-γ secretion from the PBMCs of AA patients by themselves. Anti-moesin Abs may therefore indirectly contribute to the suppression of hematopoiesis in AA patients by inducing myelosuppressive cytokines from immunocompetent cells.Keywords
This publication has 39 references indexed in Scilit:
- Specific antibodies to moesin, a membrane-cytoskeleton linker protein, are frequently detected in patients with acquired aplastic anemiaBlood, 2006
- Gα13 activation rescues moesin-depletion induced apoptosis in F9 teratocarcinoma cellsExperimental Cell Research, 2006
- Rituximab therapy of severe aplastic anemia induced by fludarabine and cyclophosphamide in a patient affected by B-cell chronic lymphocytic leukemiaLeukemia & Lymphoma, 2006
- Aplastic anemia successfully treated with rituximabAmerican Journal of Hematology, 2005
- Diazepam-binding inhibitor-related protein 1: a candidate autoantigen in acquired aplastic anemia patients harboring a minor population of paroxysmal nocturnal hemoglobinuria–type cellsBlood, 2004
- Autoantibodies frequently detected in patients with aplastic anemiaBlood, 2003
- Moesin: a potential LPS receptor on human monocytesInnate Immunity, 2001
- OKT3 first-dose reaction: Association with T cell subsets and cytokine releaseKidney International, 1991
- T Cell‐Mediated Production of Tumour Necrosis Factor‐α by MonocytesScandinavian Journal of Immunology, 1988
- Suppression of Erythroid-Colony Formation by Lymphocytes from Patients with Aplastic AnemiaNew England Journal of Medicine, 1977